Literature DB >> 8287886

Histopathological changes in androgen-deprived localized prostatic cancer. A study in total prostatectomy specimens.

M Hellström1, M Häggman, S Brändstedt, M de la Torre, K Pedersen, I Jarlsfeldt, H Wijkström, C Busch.   

Abstract

Androgen deprivation with triptorelin treatment prior to total prostatectomy gave the opportunity of studying consequent morphological changes in the surgical specimens from 38 men with localized prostatic cancer. Multiple core-needle biopsies were taken prior to treatment and compared to the step-sectioned surgical specimens. The histological changes in the prostate following androgen deprivation include glandular atrophy, nuclear pyknosis, cytoplasmic vacuolation, squamous metaplasia and an increase in the relative amount of stroma. None of these changes could be correlated to pretreatment tumour grade, nor to the volume of the residual tumour. A positive correlation was found between tumour grade prior to therapy and volume of residual tumour after treatment. The treatment was not associated with downgrading of the malignancy. On the contrary, in 16% of the cases, foci of a higher grade were found in the surgical specimens compared to the pretreatment core-needle biopsies.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8287886     DOI: 10.1159/000474350

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  8 in total

1.  Complementary medicine for prostate cancer: effects of soy and fat consumption.

Authors:  M A Moyad; W A Sakr; D Hirano; G J Miller
Journal:  Rev Urol       Date:  2001

Review 2.  Precursor lesions for prostate cancer.

Authors:  M R Feneley; C Busch
Journal:  J R Soc Med       Date:  1997-10       Impact factor: 5.344

3.  The effect of androgen deprivation on malignant and benign prostate tissue.

Authors:  P Guinan; D Didomenico; J Brown; M Shaw; R Sharifi; V Ray; S Shott; M Rubenstein
Journal:  Med Oncol       Date:  1997 Sep-Dec       Impact factor: 3.064

4.  Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy.

Authors:  Brett S Carver; Michael W Kattan; Peter T Scardino; James A Eastham
Journal:  BJU Int       Date:  2005-03       Impact factor: 5.588

5.  [(11)C]choline uptake with PET/CT for the initial diagnosis of prostate cancer: relation to PSA levels, tumour stage and anti-androgenic therapy.

Authors:  Giampiero Giovacchini; Maria Picchio; Elisa Coradeschi; Vincenzo Scattoni; Valentino Bettinardi; Cesare Cozzarini; Massimo Freschi; Ferruccio Fazio; Cristina Messa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-01-16       Impact factor: 9.236

6.  Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classification.

Authors:  Eleni Efstathiou; Neil A Abrahams; Rita F Tibbs; Xuemei Wang; Curtis A Pettaway; Louis L Pisters; Paul F Mathew; Kim-Anh Do; Christopher J Logothetis; Patricia Troncoso
Journal:  Eur Urol       Date:  2009-10-17       Impact factor: 20.096

7.  Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy.

Authors:  Roberta Mazzucchelli; Francesca Barbisan; Adriano Tagliabracci; Antonio Lopez-Beltran; Liang Cheng; Marina Scarpelli; Rodolfo Montironi
Journal:  Virchows Arch       Date:  2007-02-07       Impact factor: 4.064

Review 8.  Nondetectable Prostate Carcinoma (pT0) after Radical Prostatectomy: A Narrative Review.

Authors:  Nikolaos Kalampokis; Nikolaos Grivas; Markos Karavitakis; Ioannis Leotsakos; Ioannis Katafigiotis; Marcio Covas Moschovas; Henk van der Poel
Journal:  Curr Oncol       Date:  2022-02-23       Impact factor: 3.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.